A detailed history of Trustcore Financial Services, LLC transactions in Repligen Corp stock. As of the latest transaction made, Trustcore Financial Services, LLC holds 45 shares of RGEN stock, worth $6,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 45 -0.0%
Holding current value
$6,566
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

BUY
$161.19 - $257.96 $7,253 - $11,608
45 New
45 $8,000
Q4 2021

Feb 09, 2022

SELL
$247.59 - $304.47 $11,141 - $13,701
-45 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$180.37 - $226.26 $8,116 - $10,181
45 New
45 $9,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.1B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.